The CEO of Pfizer Inc. (NYSE: PFE), Albert Bourla, announced that it was “…a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19.”
The Pfizer vaccine news quickly catapulted the stock up and caused investors to jump on this bandwagon in the hope that the vaccine will end the economic downturn we’ve seen since March.
As investors are somewhat breathing a sigh of relief with the end of the global pandemic almost in sight, it seems as though they’re buying into the Pfizer vaccine news… but there’s something fishy going on with 60% of the company’s stock…
There’s definitely some funny business going on here… but I wonder how many traders actually noticed it…
Pfizer has dominated the news and Wall Street this entire week for one reason only — a potential COVID-19 vaccine.
On the night of Nov. 8, we saw the futures market gap higher and woke up the next morning to see Dow futures up over 1,000 points with news that Pfizer had a possible vaccine for COVID-19.
CEO Bourla then appeared on every news outlet imaginable, declaring that Pfizer’s potential vaccine was one of the biggest medical discoveries of this century…
This quickly caused the company’s stock to go on a tear, shooting up about 14%, and had Wall Street booming on the first good news in a long time.
But here’s what I find especially interesting. On the same Monday morning that Pfizer unveiled its potential COVID-19 vaccine, Bourla was selling 60% of his stock at this new high.
Seems a little shady, doesn’t it? If this vaccine was such a fantastic discovery, why wouldn’t the CEO keep his shares? Is he so money hungry that he needed an extra $5.6 million in the bank?
Here’s what I found out about Bourla’s stock sell plan… and what it means for insider buyers.
Watch today’s video to learn everything you need to know about the truth behind the Pfizer vaccine news. And after you watch the video below, leave a comment. Have you had luck trading Pfizer recently? What do you think about the CEO selling 60% of his shares? Let me know!